Halozyme Therapeutics, Inc.
HALO
$62.99
$0.450.72%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -10.54% | 25.95% | 14.15% | 37.93% | -30.48% |
Total Receivables | 7.95% | 33.20% | 9.51% | -16.36% | 7.77% |
Inventory | 7.95% | -17.51% | -5.48% | 32.08% | -1.02% |
Prepaid Expenses | -10.49% | -48.76% | 85.89% | -6.01% | -1.75% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -3.69% | 14.09% | 13.07% | 17.04% | -15.08% |
|
|||||
Total Current Assets | -3.69% | 14.09% | 13.07% | 17.04% | -15.08% |
Net Property, Plant & Equipment | 0.73% | -0.68% | -3.93% | 4.17% | 0.37% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -4.23% | -4.06% | -3.90% | -3.76% | -3.62% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.36% | 52.72% | 192.62% | -19.22% | -29.57% |
Total Assets | -2.58% | 7.54% | 6.95% | 6.25% | -8.42% |
|
|||||
Total Accounts Payable | -17.33% | -19.65% | 15.80% | 12.77% | -38.83% |
Total Accrued Expenses | 26.33% | 110.26% | -21.93% | -41.66% | 173.75% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -72.06% | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | 21.86% | -- | -- |
Total Other Current Liabilities | -- | -- | 21.86% | -- | -- |
Total Current Liabilities | 27.83% | -18.41% | 1.31% | 17.02% | -2.34% |
|
|||||
Total Current Liabilities | 27.83% | -18.41% | 1.31% | 17.02% | -2.34% |
Long-Term Debt | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -23.09% | 0.81% | -2.22% | -3.09% | 13.28% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 43.98% | 58.30% | -- | -- | 145.14% |
Total Liabilities | 2.06% | -0.88% | 0.98% | 0.86% | 0.36% |
|
|||||
Common Stock & APIC | -99.80% | 100.86% | 158.99% | 370.07% | -90.12% |
Retained Earnings | -9.50% | 52.57% | 55.71% | 84.84% | -59.26% |
Treasury Stock & Other | 155.18% | -235.54% | -39.17% | 83.98% | -856.15% |
Total Common Equity | -19.63% | 56.42% | 62.77% | 112.16% | -66.37% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -19.63% | 56.42% | 62.77% | 112.16% | -66.37% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -19.63% | 56.42% | 62.77% | 112.16% | -66.37% |
|